Description: Ferimac Injection is an iron replacement product, a complex of polynuclear iron (III)-hydroxide in sucrose for intravenous use. It is used to treat iron deficiency anemia.
Dosage Form: Injection
Route of Administration: IV
Composition:
Each 5 ml ampoule contains:
Ferric Hydroxide in Complex with Sucrose equivalent to elemental Iron 100 mg
Water for Injections IP q.s.
Mechanism of Action: Ferimac Injection is an aqueous complex of poly-nuclear iron (III)-hydroxide in sucrose. Following intravenous administration, it is dissociated into iron and sucrose and the iron is transported as a complex with transferrin to target cells including erythroid precursor cells. The iron in the precursor cells is incorporated into haemoglobin as the cells mature into red blood cells.
Indications: Ferimac Injection is indicated for the treatment of iron deficiency anemia (IDA) in patients with chronic kidney disease (CKD).
Dosage: As directed by the physician.
Side effects: The most common side effects: Headache, Respiratory tract viral infection, Peritonitis, Vomiting, Pyrexia, Dizziness, Cough, Nausea, Arteriovenous Fistula thrombosis, Hypotension, Hypertension
Contraindications: Ferimac Injection is contraindicated in patients with known hypersensitivity to any of the ingredients.
Drug interactions: Ferimac Injection may reduce the absorption of concomitantly administered oral iron preparations.
Storage: Store at controlled room temperature. Do not freeze.
Presentation: 18x10x1x5ml